Calprotectin may be used as a biomarker in cases of suspected IBD, in differentiation from irritable bowel syndrome (IBS), in monitoring of disease activity, predicting remission, monitoring response to anti-TNFα therapy, and detecting postoperative recurrence in CD [44]. Here, TNF is linked to irritable bowel syndrome.